Awakn Life Sciences Corp. (AWKNF)
Stock analysis · OTC · Healthcare · Biotechnology
$0.07
Market Cap
$2.71M
PE (TTM)
-0.70
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
2.60
Day Range
$0.07 – $0.08
52-wk Range
$0.05 – $0.13
Avg Volume
N/A
Volume
35.00
Awakn Life Sciences Corp. (AWKNF) is a publicly traded company in the Healthcare sector. Latest price: $0.07. Market cap $2.71M. Trailing PE -0.70. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Most Recent
May 28, 2024
EPS $-0.01 vs est. $-0.02
Beat by $0.01
Proprietary Signals
About Awakn Life Sciences Corp.
Awakn Life Sciences Corp., a biotechnology firm, focuses on pioneering, advancing, implementing, and distributing psychedelic therapies to combat addiction and various other mental health conditions. Operating across the United Kingdom and Europe, the company maintains its corporate headquarters in Toronto, Canada.
Valuation
| P/E (TTM) | -0.70× |
|---|---|
| P/S (TTM) | 43.58× |
| P/B | -1.74× |
| P/FCF (TTM) | -1.60× |
| EV / EBITDA | -0.87× |
| EV / Sales | 38.92× |
| Earnings Yield | -192.07% |
| Free Cash Flow Yield | -62.54% |
Fundamentals
| Enterprise Value | $3.40M |
|---|---|
| Revenue (TTM) | $87.37K |
| Net Income (TTM) | -$7.31M |
| Free Cash Flow (TTM) | -$2.38M |
| Net Debt | -$407.30K |
| Working Capital | -$1.58M |
| Gross Margin | 100.00% |
| Operating Margin | -4493.94% |
| Net Margin | -5840.14% |
| Return on Equity | 1495.19% |
| Return on Invested Capital | 256.59% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap